- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Pfizer to Acquire Metsera with Next-Generation Obesity Portfolio
Feb 24, 2026
Newleaf Brands Announces Newest Newleaf Brands Advisor Appointee, Dr. Aubrey Oliver, set to Spearhead Jamaican-based Psilocybin Healing Retreat Efforts
May 26, 2020
Monoclonal Antibody Therapeutics (mABs) Market is expected to reach US$ 542.80 billion by 2030
Feb 05, 2024
Radioactive Tracer Market is expected to reach US$ 54,296.57 million by 2030
Aug 11, 2023
Medical Marijuana, Inc. Appoints New Chief Financial Officer
Dec 18, 2019
Doctors and health experts urged people not to drink or inject disinfectant
Apr 24, 2020
Is Hydroxychloroquine Really a Game Changer in the fight against COVID-19?
Apr 15, 2020
Follow us on
